Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

NCT03184584 is registered in ClinicalTrials.gov with Liminal BioSciences Ltd. as lead sponsor.

NCT NCT03184584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03184584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
Lead sponsor
Liminal BioSciences Ltd.
Phase
Phase 2/3
Overall status
Terminated
Start date
October 9, 2017
Completion date
May 8, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alström syndrome